Robert A. Bradway - 17 Mar 2025 Form 4 Insider Report for AMGEN INC (AMGN)

Role: Chairman, CEO and President, Director
Signature: /s/ Robert A. Bradway
Issuer symbol: AMGN
Transactions as of: 17 Mar 2025
Net transactions value: -$4,032,115
Form type: 4
Filing time: 19 Mar 2025, 20:15:24 UTC
Previous filing: 05 Mar 2025
Next filing: 03 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMGN	Common Stock	Tax liability	$4,032,115	-12,853	-2.1%	$313.71	587,565	17 Mar 2025	Direct	F1
holding	AMGN	Common Stock						90,000	17 Mar 2025	By GRAT
holding	AMGN	Common Stock						90,000	17 Mar 2025	By Spousal GRAT

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares include 2,782 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Content

These shares include 2,782 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.